| Title : Effects of simultaneous versus post exposure epigallocatechin-3-gallate treatment on aluminum induced neurotoxicity in rat hippocampus: A multi-approach study - Palabiyik-Yuceli_2023_Environ.Toxicol.Pharmacol_98_104061 |
| Author(s) : Palabiyik-Yuceli KS , Zeybek ND , Cinar I , Akpinar E , Bahador Zirh E , Si Pahi H , Halici Z |
| Ref : Environ Toxicol Pharmacol , 98 :104061 , 2023 |
|
Abstract :
Chronic aluminium(Al) exposure can affect the antioxidant and glutaminergic systems through N-methyl-D-aspartate receptors (NMDAR). This study was aimed to investigate the neurotoxic effect of Al through different mechanisms in rat hippocampus and to evaluate the protective role of epigallocatechin gallate (EGCG), a well-known antioxidant, with simultaneous administration of Al,as well as post-treatment after Al exposure.For this purpose, aluminum chloride(AlCl(3)) was administered simultaneously with two different EGCG doses for 8 weeks as the first part of the study.In the second part of the study, after 4 weeks of AlCl(3) pre-administration, two different EGCG doses were also administered during four additional weeks as post-treatment.Al administration led to oxidative stress and increased acetylcholinesterase levels.NMDAR subunit mRNA expressions were down-regulated by Al, which was apparent in NMDAR1/2B subunits.Simultaneous EGCG treatment has shown a better neuroprotective effect in terms of these mechanisms and represents novel approach for the prevention of neurodegenerative diseases likely to be induced by Al. |
| PubMedSearch : Palabiyik-Yuceli_2023_Environ.Toxicol.Pharmacol_98_104061 |
| PubMedID: 36621558 |
Palabiyik-Yuceli KS, Zeybek ND, Cinar I, Akpinar E, Bahador Zirh E, Si Pahi H, Halici Z (2023)
Effects of simultaneous versus post exposure epigallocatechin-3-gallate treatment on aluminum induced neurotoxicity in rat hippocampus: A multi-approach study
Environ Toxicol Pharmacol
98 :104061
Palabiyik-Yuceli KS, Zeybek ND, Cinar I, Akpinar E, Bahador Zirh E, Si Pahi H, Halici Z (2023)
Environ Toxicol Pharmacol
98 :104061